Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer??s Disease and Other Dementias
- 1 January 2006
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 24 (3) , 265-280
- https://doi.org/10.2165/00019053-200624030-00006
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Galantamine Maintains Ability to Perform Activities of Daily Living in Patients with Alzheimer's DiseaseJournal of the American Geriatrics Society, 2004
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJAMA, 2004
- Update on RivastigmineThe Neurologist, 2003
- Treatment of Alzheimer's DiseaseNew England Journal of Medicine, 1999
- Utility of Mini-Mental State Exam Scores in Predicting Functional Impairment Among White and African American Dementia PatientsThe Journals of Gerontology: Series A, 1996
- An Intervention That Delays Institutionalization of Alzheimer's Disease Patients: Treatment of Spouse-CaregiversThe Gerontologist, 1993
- The Economic Burden of Alzheimer's Disease CareHealth Affairs, 1993
- The Effect of Dementia on Acute Care in a Geriatric Medical UnitInternational Psychogeriatrics, 1992
- Assessment of Functional Ability in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1992
- Studies of Illness in the AgedJAMA, 1963